Search results
Sanofi (SNY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 hours agoImage source: The Motley Fool. Sanofi (NASDAQ: SNY) Q1 2024 Earnings Call Apr 25, 2024, 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers...
Regeneron, Sanofi to seek new Dupixent approval in US after COPD success
BioPharma Dive via Yahoo Finance· 5 months agoResults from the second of two Phase 3 trials testing the blockbuster drug in the respiratory...
What This Drug News Could Mean for Sanofi Shareholders
Motley Fool· 1 year agoIn the middle of December, Sanofi's (NASDAQ: SNY) and Regeneron Pharmaceuticals' (NASDAQ: REGN)...
Sanofi Expects Moderate 2023 Profit Growth On Dupixent Demand, But Dampened By Aubagio Generics...
Benzinga via Yahoo Finance· 1 year agoSanofi SA (NASDAQ: SNY) forecasts 2023 adjusted earnings per share to grow by a "low single-digit"...
Regeneron Pharmaceuticals Inc (REGN) Reports Modest Revenue Growth Amidst Strong Dupixent Sales
GuruFocus.com via Yahoo Finance· 3 months agoRevenue Growth: Full year 2023 revenues increased by 8% to $13.12 billion, with a 14% rise excluding...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2022 Earnings Call Transcript (Corrected)
Insider Monkey via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2022 Earnings Call Transcript February 3, 2023...
Regeneron Pharmaceuticals Inc (REGN) Reports 15% Revenue Growth in Q3 2023
GuruFocus.com via Yahoo Finance· 6 months agoRegeneron Pharmaceuticals Inc (NASDAQ:REGN) reported a 15% increase in revenues to $3.36 billion in...
Sanofi trial failure halts work on breast cancer treatment amcenestrant
Reuters via Yahoo News· 2 years agoSanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial...
Analysis-Meagre medicine cabinet leaves Sanofi unloved
Reuters via Yahoo News· 2 years agoSanofi's recent stock rout underscores the pressure on the French drug maker to redouble its efforts...
Q1 2023 Regeneron Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 12 months agoParticipants George D. Yancopoulos; Co-Founder, President, Chief Scientific Officer & Director; Regeneron Pharmaceuticals, Inc. Leonard S. Schleifer; Co-Founder, President, CEO & Director; Regeneron ...
